US Stock MarketDetailed Quotes
BLRX BioLine Rx
- 0.552
- +0.016+2.91%
Trading Nov 20 13:30 ET
44.13MMarket Cap-1218P/E (TTM)
0.560High0.521Low245.66KVolume0.530Open0.536Pre Close133.45KTurnover0.34%Turnover RatioLossP/E (Static)79.94MShares1.89052wk High3.15P/B40.20MFloat Cap0.39052wk Low--Dividend TTM72.83MShs Float103.050Historical High--Div YieldTTM7.35%Amplitude0.390Historical Low0.543Avg Price1Lot Size
About BioLine Rx Company
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.
Company Profile
SymbolBLRX
Company NameBioLine Rx
Listing DateJul 25, 2011
Founded2003
CEOMr. Philip A. Serlin, C.P.A.,M.B.A.
MarketNASDAQ
Employees79
Securities TypeDR
ADS Ratio1.0 : 15.0
Fiscal Year Ends12-31
AddressModi'in Technology Park,2 HaMa'ayan Street
CityModi'in
ProvinceHaMerkaz
CountryIsrael
Zip Code7177871
Phone972-8-642-9100
Websitehttp://www.biolinerx.com
Company Executives
- Name
- Position
- Salary
- Philip A. Serlin, C.P.A.,M.B.A.
- Chief Executive Officer
- 952.00K
- Mali Zeevi, C.P.A.
- Chief Financial Officer
- 443.00K
- Dr. Ella Sorani, PhD
- Chief Development Officer
- 520.00K
- Holly W. May, M.B.A.
- President, US
- 1.01M
- Dr. Aharon Schwartz,PhD
- Chairman of the Board
- --
- Dr. Shaoyu Yan, PhD
- Director
- --
- Rami Dar, M.B.A.
- Independent Director
- --
- Gal Cohen
- Independent Director
- --
- Dr. Sandra Panem,PhD
- Independent Director
- --
- Dr. Raphael Hofstein, PhD
- Independent Director
- --
- Dr. B. J. Bormann, PhD
- Independent Director
- --
- Dr. Avraham Molcho, M.D.
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
